维灵(VivaLNK)与斯坦福大学携手,探究压力与青少年抑郁的关联性。

维灵(VivaLNK)与斯坦福大学于近期达成合作,维灵自主研发的Vital Scout健康监测贴片将助力斯坦福精神病学与行为科学系的研究人员,用以实时长效追踪青少年压力指数与其他关键生理参数,该项目意在探究压力水平与青少年抑郁之间是否存在相关性


Vital Scout是一款基于维灵eSkin®电子皮肤专利技术生产的医疗级柔性可穿戴设备,其大小与创口贴类似,通过心电图(ECG)传感和心率变异性(HRV)算法,可持续量化衡量日常活动对于人体产生的影响,减少因随机压力测量而引起的误差;Vital Scout还可追踪睡眠质量、心率和呼吸率等。


mHealthIntelligence等海外众多媒体对其进行了报道,称维灵与斯坦福大学的此次合作,是包括FitbitGarminApple在内的,面向个人医疗消费市场的企业与医疗机构、专业研究人员的又一次携手。


 - Stanford University is using an mHealth wearable in a new study looking for a connection between stress and depression in teenagers.


Researchers in Stanford’s Department of Psychiatry and Behavioral Science are using the Vital Scout, a Band-Aid-sized digital health patch that uses sensors - including electrocardiogram (ECG) measurement - to continuously monitor heart and respiratory rate, sleep, activity and other functions.


The patch was unveiled by California-based VivaLNK at the CES show in Las Vegas as a consumer product, enabling users to monitor their own stress levels for up to 72 hours at a time through a patch affixed to one’s chest.


The company is loaning the mHealth devices to Stanford for its research, which will track teens via remote patient monitoring for 24-hour stretches.


“Until recently, quantifying stress has been difficult,” Jiang Li, the company’s CEO, said in a press release. “Now with wearable sensors, quality data, and a better understanding of physiological impacts, we are able to provide a window into how daily activities affect our well-being in a quantifiable way.”


The agreement with Stanford is another example of collaboration between the consumer-facing digital health market and healthcare providers and researchers. VivaLNK is one of several companies – including Fitbit, Garmin and Apple – looking to bridge that gap by offering mHealth platforms that can be clinically validated.


Among the more promising form factors is the mHealth patch.


Just a few months ago, the San Diego-based Scripps Research Translational Institute reported that a patch designed by iRhythm was three times better at identifying atrial fibrillation than the traditional doctor’s office exam. And in June, researchers at Jefferson Health’s Sidney Kimmel Cancer Center launched a project  in which a patch used to measure breathing patterns in people with asthma might be used to detect early signs of pneumonia in patients undergoing lung cancer treatment.


Researchers and healthcare providers have also been using so-called smart patches for medication adherence and medication management, as well as to remotely deliver times doses of medication.


At Boston’s Brigham and Women’s Hospital, meanwhile, a roughly two-year-old RPM program is using mHealth patches developed by Vital Connect to keep track of patients at home after they’ve been discharged from the hospital.   


“The evolution of digital medicine makes us even more confident in the home hospital model for our patients,” David Levine, MD, a General and Internal Medicine Fellow at Brigham and Women’s and the study’s principal investigator, said in a December 2016 press release announcing the initial study. “The purpose of this study is to show how we can deliver superior outcomes at a lower cost for patients who otherwise would be hospitalized.”


“We are in a very exciting era of medicine where clinical-grade biosensors and analytics are capable of delivering continuous physiological insight that was traditionally only available in the hospital environment,” he added.